Curriculum vitae
PERSONAL INFORMATION
Giacomo Grassi
Via Dei Serragli 33, 50124 Florence (Italy)
(+39) 3475337031
[email protected]
Skype giacomograssi
Sex Male | Date of birth 19/11/1984 | Nationality Italian
WORK EXPERIENCE
15/06/2015–Present
Clinical and research activity
Institute of Neuroscience, Florence (Italy)
17/05/2003–17/05/2009
Clinical activity at the Psychiatric Unit of the University of Florence
EDUCATION AND TRAINING
17/05/2010–17/05/2015
Residency in Psychiatry
70/70 cum laude
University of Florence, Florence (Italy)
Dissertation’s title: “Atomoxetine for hoarding disorder: a pre-clinical and clinical investigation”.
Superviisors: Prof. Stefano Pallanti M.D., Ph.D. , Prof. Carla Ghelardini Ph.D.
01/10/2013–01/02/2014
Internship at the University of Amsterdam
Academic Medical Center, Amsterdam (Netherlands)
Training and research activity on Deep-Brain Stimulation for Obsessive-Compulsive Disorder and
Mood Disorders.
Supervisors: Damiaan Denys, M.D., Ph.D. and Martijn Figee, M.D., Ph.D.
01/01/2007–31/10/2007
Long Life Learning Program
Universitée René Descartes, Paris (France)
Clinical activity in otrhopedic surgery at Hopital Cochin (Paris V)
Clinical activity in interna medicine at Hopital Saint Michel (Paris XIII)
10/2003–19/10/2009
Graduation in Medicine and Surgery
110/110
University of Florence, Florence (Italy)
Dissertation’s title: “Aripiprazole augmentation for obsessive-compulsive patients with treatmentresistance to the association SSRI + risperidone: a single-blinded study”.
Superviisor: Prof. Stefano Pallanti M.D., Ph.D.
PERSONAL SKILLS
Mother tongue(s)
Other language(s)
Italian
UNDERSTANDING
Listening
16/7/15
Reading
SPEAKING
Spoken interaction
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
WRITING
Spoken production
Page 1 / 3
Curriculum vitae
English
French
Giacomo Grassi
C1
C1
C1
C1
B2
C1
C1
C1
C1
B2
Levels: A1 and A2: Basic user - B1 and B2: Independent user - C1 and C2: Proficient user
Common European Framework of Reference for Languages
ADDITIONAL INFORMATION
Memberships
International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)
Italian Society of Psychiatry (SIP)
Honours and awards
Publications
Fellowship Award 2015 for youngpsychiatrist of the Japanese Society of Psychiatry and
Neurology. JSPN-WPA congress, Osaka (Japan) june 4th-6th2015
Peerreviewed papers
Grassi G, Godini L, Grippo A, Piccagliani D, Pallanti S. Enhancing cognitive-behavioral therapy with
repetitive transcranial magnetic stimulation in refractory obsessive-compulsive disorder: a case report.
BrainStimul. 2015 Jan-Feb;8(1):160-1
Pallanti S, Grassi G, Pharmacologic treatment of obsessive-compulsive disorder comorbidity. Expert
Opin Pharmacother. 2014 Dec; 15(17): 2543-52.
Pallanti S, Grassi G, Cantisani A. Emerging drugs to treatobsessive-compulsive disorder. Expert
Opin Emerg Drugs. 2014 Mar;19(1):67-77.
Pallanti S, Grassi G, Antonini S, Quercioli L, Salvadori E, Hollander E. rTMSin resistant mixed states:
an exploratory study. J Affect Disord.,157:66-71;2014.
GrassiG, Poli L,Cantisani A, Righi L, Ferrari G, Pallanti S. Hypochondriasis and obsessivecompulsivedisorder in schizophrenic patients treated with clozapine vs other atypicalantipsychotics.
CNS Spectrum, 2014;19(4):340-6.
Grassi G, Pallanti S. Citalopram Pulse-Loading forSevere Treatment-Resistant OCD: A Case Series
of Acute Response, One YearFollow-Up and Tolerability. J Depress Anxiety, 2013.
Pallanti S, Grassi G, Tofani L, Spitoni S. Pharmacologicaltreatments for behavioral addictions: from
behavioral dimensions to theResearch Domain Criteria based target. Current Psychopharmacology.
2013.
Pallanti S, Grassi G, Ramella-Cravaro V. From psychopatology toneurocircuits: what we can learn
from DBS? The case of obsessive-compulsivedisorder. Journal of Psychopathology. 2013, in press
Pallanti S, Cantisani A, Grassi G. Anxiety as a core aspect of schizophrenia. Curr Psychiatry
Rep.2013, 15(5):354.
Pallanti S,Grassi G, Cantisani A. Is hoarding aseparate disorder? Neuropsychiatry, 2012, 2(5): 365367.
Pallanti S, Cantisani A, Grassi G, Antonini S, Cecchelli C,Burian J, Cauli G, Quercioli L. rTMS agedependent response intreatment-resistant depressed subjects: a mini-review. CNS Spectr. 2012,
17(1):24-30.
Pallanti S, Grassi G, Burian J. Dopamine Pharmacological Agents in Resistant-OCD.Current
Psychopharmacology, 2012, 1: 44-46
Pallanti S, Grassi G, Sarrecchia ED, Cantisani A, Pellegrini M.Obsessive-compulsive disorder
comorbidity: clinical assessment and therapeuticimplications. Front Psychiatry. 2011, 2:70.
Cecchelli C, Grassi G, Pallanti S. Aripiprazole Improves Depressive Symptoms andImmunological
Response to Antiretroviral Therapy in an HIV-Infected Subjectwith Resistant Depression. Case Report
Med. 2010.
Bookchapters
Pallanti S, Grassi G, Cantisani A. Approachesto treatment resistance. Obsessive Compulsive
Disorder: Current Science andClinical Practice. World Psychiatry Association. Wiley-Blackwell (Ed.).
16/7/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 2 / 3
Curriculum vitae
Giacomo Grassi
2012
Pallanti S, Grassi G, Cantisani A. The Treatment of Obsessive-CompulsiveDisorder and the
Approaches to Treatment Resistance, Different Views of AnxietyDisorders, Salih Selek (Ed.), ISBN:
978-953-307-560-0, InTech. 2011
Presentations
“Newconceptualizations of obsessive-compulsive disorder: the behavioral addictionmodel” JSPNWPA congress 2015, 4th-6th June, Osaka,Japan.
“Neuroscientif tools for forensic psychiatry”JSPN-WPA congress 2015, 4th-6th June, Osaka, Japan.
"Impulsivity, decision-making and reward functioning in obsessive-compulsive disorder (OCD) and
pathological gambling: probing the behavioral addiction model of OCD". 2nd International Conference
on Behavioral Addictions, March 16-18, 2015, Budapest, Hungary.
“Reduced loss avoidance and overconfidence in obsessive-compulsivedisorder: a neuroeconomic
perspective”. EPA European Psychiatric Congress 2014,1-4 March, Munich, Germany
“Obsessive–compulsive disorder clinical staging: From endophenotype tobehavioral addiction”.
1stInternational Conference on Behavioral Addictions March 11–12, 2013 Budapest,Hungary
“Workshop on Obsessive Compulsive-Disorder”. October 26, 2012 Lugano,Switzerland.
Posters
"Citalopram pulse-loading for treatment-refractory obsessive-compulsive disorder: preliminary data
from an open-label trial". Grasssi G and Pallanti S. 25th ECNP Congress 18-21 October 2014, Berlin,
Germany.
“Obsessive–compulsive disorder clinical staging: From endophenotype tobehavioral addiction: a
theoretical framework”. Grassi G. EPA European Psychiatric Congress 2014, 1-4March, Munich,
Germany
“Hypochondrias and obsessive-compulsive disorder in schizophrenicpatients treated with clozapine vs
other atypical antipsychotics”. Grassi G,Poli L, Pellegrini M, Pallanti S. 25thECNP Congress13-17
October 2012, Vienna, Austria.
Web Intervies
http://www.newscientist.com/article/mg22129603.400...
Research fields
Obsessive-Compulsive and related Disorders
Impulsivity and Compulsivity
Decision-making
Behavioral Addictions
Neuromodulation tecniques
16/7/15
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 3 / 3